Initial proceeds extend cash runway into the first half of 2027 NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (INAB), a clinical-stage biopharmaceutical company developing innovative γδ T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results